4//SEC Filing
Herberts Curt A. III 4
Accession 0001209191-18-016866
CIK 0001001233other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 6:39 PM ET
Size
22.1 KB
Accession
0001209191-18-016866
Insider Transaction Report
Form 4
Herberts Curt A. III
Senior VP & CBO
Transactions
- Exercise/Conversion
Common Stock
2018-03-01$14.07/sh+8,087$113,784→ 24,313 total - Sale
Common Stock
2018-03-01$23.06/sh−15,000$345,861→ 14,625 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-03-01−8,087→ 11,913 totalExercise: $14.07Exp: 2024-12-10→ Common Stock (8,087 underlying) - Exercise/Conversion
Common Stock
2018-03-01$12.12/sh+171$2,073→ 14,796 total - Exercise/Conversion
Common Stock
2018-03-01$9.41/sh+1,430$13,456→ 16,226 total - Exercise/Conversion
Common Stock
2018-03-01$3.50/sh+5,312$18,592→ 29,625 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-03-01−171→ 0 totalExercise: $12.12Exp: 2023-12-11→ Common Stock (171 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2018-03-01−1,430→ 17,320 totalExercise: $9.41Exp: 2025-12-07→ Common Stock (1,430 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2018-03-01−5,312→ 54,688 totalExercise: $3.50Exp: 2027-01-25→ Common Stock (5,312 underlying)
Footnotes (7)
- [F1]All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017.
- [F2]The price reported is a weighted average price. The shares were sold at prices ranging from $22.60 to $23.60 The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Includes (a) 8,375 shares subject to restricted stock units granted on January 24, 2018 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date; and (b) 6,250 shares subject to restricted stock units granted on December 8, 2015 that will vest on December 8, 2018, subject to the Reporting Person's continued service with the Issuer through such date.
- [F4]Fully vested and exercisable.
- [F5]One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the December 11, 2014 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date.
- [F6]One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the December 8, 2015 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date.
- [F7]The stock option vested and became exercisable for 25% of the shares upon the Reporting Person's completion of one year of service measured from the January 26, 2017 grant date, and the balance of the shares will vest and become exercisable in 36 successive equal monthly installments upon his completion of each additional month of service thereafter.
Documents
Issuer
SANGAMO THERAPEUTICS, INC
CIK 0001001233
Entity typeother
Related Parties
1- filerCIK 0001691262
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 6:39 PM ET
- Size
- 22.1 KB